Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
Location status: Recruiting
Location contact
Christina Tulbert
CONTACT
Joshua F Nitsche, MD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT06412978
Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Several recent reviews have summarized the evidence for various steps of cesarean delivery, but surprisingly in many cases there is little scientific evidence on which to base the choice of surgical technique.
Interested in participating?
Request Info18 year–44 year
Female
Interventional
Not applicable
Winston-Salem, North Carolina, 27157, United States
Location status: Recruiting
Christina Tulbert
CONTACT
Joshua F Nitsche, MD
PRINCIPAL_INVESTIGATOR
Cesarean delivery is the most common surgical procedure performed in the United States, with over 1 million procedures performed per year. Based on recent Center for Disease Control (CDC) National Vital Statistics Report (2021) 32.1% of all births in the United States were via cesarean delivery. Given the high numbers of cesarean deliveries being performed today, there has been interest in optimizing surgical techniques. Absorbable staples, made from a combination of polylactic and polyglycolic acid, are a relatively new option for skin closure at the time of surgery. This study is a randomized trial that will investigates two cesarean skin closure techniques-subcuticular, polyglecaprone suture (Monocryl), and absorbable subcuticular polyglycolic acid staples (INSORB)-to determine if one is associated with better scar cosmesis.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Insorb absorbable staples are used for skin closure
Other names: INSORB
Monocryl absorbable staples are used for skin closure
Other names: Monocryl
Time frame: Week 6
Scars will be digitally photographed by study staff and scored by 2 independent judges (attending Obstetricians) according to the SCAR scale validated by Kantor with scores ranging from 0 (best) to 15 (worst).
Time frame: Week 6
wound complications (infection, dehiscence, seroma, hematoma, skin and fat necrosis, skin and fascial dehiscence)
Time frame: Week 6
days spent in hospital
Time frame: Week 6
amount of in-hospital intravenous opiate analgesic use
Time frame: Week 6
amount of in-hospital oral NSAID analgesic use
Time frame: Week 6
amount of in-hospital oral opiate analgesic use
Time frame: Week 6
patient rated subjective pain score (0-10 based on visual analog scale) - 100-mm visual analog scale (VAS) ratings of 0 to 4 mm can be considered no pain; 5 to 44 mm, mild pain; 45 to 74 mm, moderate pain; and 75 to 100 mm, severe pain.
Time frame: Week 6
The Patient and Observer Scar Assessment Scale (POSASA) All items are scored on a scale ranging from 1 ('like normal skin') to 10 ('worst scar imaginable'). Higher scores meaning more scarring
Contact information is provided by the study sponsor or research team.
Wake Forest University Health Sciences
Other
Post-Operative Cosmesis and Skin Closure Methods After Cesarean Section
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07082530
Cesarean Delivery
Hangzhou, Zhejiang, China
View Trial DetailsNCT07362992
Blood Loss, Surgical, Cesarean Delivery
Holon, Central District, Israel
View Trial DetailsNCT06030063
Cesarean Delivery, General Anesthesia
Little Rock, Arkansas, United States
View Trial DetailsNCT07326644
Body Weight, Body Weight Changes
Elâzığ, Elaziğ, Turkey (Türkiye)
View Trial Details